|
Volumn 64, Issue 4, 2000, Pages 319-321
|
Tributyrin plus all-trans-retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemia cells
a,b a a |
Author keywords
hemoglobinopathies; Butyrate, K562 cells; Fetal hemoglobin; Retinoic acid; Tributyrin
|
Indexed keywords
BUTYLAMINE;
BUTYRALDEHYDE;
BUTYRIC ACID;
BUTYRIC ACID DERIVATIVE;
BUTYRYLCHOLINE IODIDE;
GAMMA BUTYROLACTONE;
HEMOGLOBIN F;
RETINOIC ACID;
TRIBUTYRIN;
ARTICLE;
CELL STRAIN K 562;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MECHANISM;
DRUG POTENTIATION;
HEMOGLOBIN DETERMINATION;
HEMOGLOBINOPATHY;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN INDUCTION;
ANTINEOPLASTIC AGENTS;
FETAL HEMOGLOBIN;
HUMAN;
K562 CELLS;
LEUKEMIA, ERYTHROBLASTIC, ACUTE;
SUPPORT, NON-U.S. GOV'T;
TRETINOIN;
TRIGLYCERIDES;
|
EID: 0033861924
PISSN: 03618609
EISSN: None
Source Type: Journal
DOI: 10.1002/1096-8652(200008)64:4<319::AID-AJH16>3.0.CO;2-D Document Type: Article |
Times cited : (17)
|
References (10)
|